The material terms of these Loan Funded Shares are as follows: 1. The Managing Director has the opportunity to purchase the Loan Funded Shares at a market price of $0.071 per Loan Funded Share, being the closing share price at 31 December 2023. 2. The Loan is interest free, limited recourse loan for a period of up to seven years. The limited recourse nature of the Loan means that if the Loan Funded Shares do not vest for any reason, or their market value is less than the outstanding loan value when the Managing Director is required to repay the Loan, the liability will be limited to the value of the Shares. That is, the Company cannot require the the Managing Director to repay an amount greater than the market value of the Loan Funded Shares. 3. In order to benefit from the Incentive Plan, the Managing Director must remain employed or continue to provide services to the Company and satisfy the Vesting Conditions. 4. To the extent that the Vesting Conditions are met, the Managing Director will be able to repay the Loan and dispose of the Shares. The Managing Director can choose to repay the Loan at any time the employees Loan Funded Shares have vested up until the Loan becomes repayable being up to 7 years. 5. The Vesting Conditions are as follows: A share Price Hurdle of $0.088 being a 25% premium to the 5 day VWAP ending 31 December 2023 by 31 December 2024 (this hurdle must be reached on at least 20 trading days, not necessarily consecutive, by 31 December 2024). Vesting period commences on the grant date, being 19 November 2024 and ends on 31 December 2024. As at 31 December 2024, the vesting condition had been met for all Loan Funded Shares. Additional information The factors that are considered to affect total shareholders return (‘TSR’) are summarised below: 2025 2024 2023 2022 2021 Share price at financial year end (cents) 5.40 6.60 4.30 19.50 64.50 Share price HIGH for the financial year ended 30 June (cents) 14.10 14.10 30.00 69.50 95.00 Share price LOW for the financial year ended 30 June (cents) 4.90 3.40 3.90 17.50 18.50 Additional disclosures relating to key management personnel Shareholding The number of shares in the company held during the financial year by each director and other members of key management personnel of the consolidated entity, including their personally related parties, is set out below: Balance at the start of the year Received as part of remuneration Additions Disposals / Other Balance at the end of the year Ordinary shares Mr. Frederic Bart 7,507,813 - - - 7,507,813 Mr. Peter Marks 900,000 - - - 900,000 Mr. Boris Patkin 630,000 - - - 630,000 Dr. Gisela Mautner - 350,000 - - 350,000 9,037,813 350,000 - - 9,387,813 Annual Report 2025 20
RkJQdWJsaXNoZXIy MjE2NDg3